Summary Comments
- Most frequently detected viruses in July (all ages):
- Rhino/Enterovirus: 25.2%
- Influenza B: 16.2%
- Epidemiological Week 1–30:
- SARS-CoV-2: Stable over the last 4 weeks
- Influenza A: Peaked at 43.6% in week 20, declined to 2.2% by week 30
- Influenza B: Increased to 22.6% in week 30
- RSV: Peaked at 27.8% in week 13, declined to 5% by week 30
Respiratory Viral Multiplex PCR and SARS-CoV-2 PCR: All Age Groups
June 2024:
- Rhino/Enterovirus: 21.1%
- Rhinovirus: 13.7%
- RSV: 9.6%
- SARS-CoV-2: 6.1%
- Influenza A: 3.0%
- Influenza B: 18.4%
- Parainfluenza 1-4: 7.4%
- Adenovirus: 3.1%
- Metapneumovirus: 8.0%
July 2024:
- Rhino/Enterovirus: 25.2%
- Rhinovirus: 11.7%
- RSV: 6.2%
- SARS-CoV-2: 5.9%
- Influenza A: 2.0%
- Influenza B: 16.2%
- Parainfluenza 1-4: 3.6%
- Adenovirus: 1.9%
- Metapneumovirus: 7.3%
Atypical Bacterial Pathogens (Week 1–30)
Detected Pathogens:
- B. pertussis, M. pneumoniae, C. pneumoniae (circulating at low levels)
- Legionella pneumophila: 4 cases in July
Age Distribution:
Bordetella pertussis:
- 0–6 months: 16%
- 6–12 months: 7%
- 1–5 years: 28%
- 6–12 years: 20%
- 13–18 years: 5%
- 19–64 years: 18%
65 years: 6%
Mycoplasma pneumoniae:
- 0–6 months: 2%
- 6–12 months: 6%
- 1–5 years: 27%
- 6–12 years: 29%
- 13–18 years: 7%
- 19–64 years: 25%
65 years: 4%
Chlamydia pneumoniae:
- 0–6 months: 3%
- 6–12 months: 4%
- 1–5 years: 45%
- 6–12 years: 30%
- 13–18 years: 4%
- 19–64 years: 13%
65 years: 1%
Paediatric Respiratory Viral Multiplex PCR Data (Ages 0–12)
<1 Year Age Group
June 2024:
- Rhino/Enterovirus: 34.7%
- Rhinovirus: 24.3%
- RSV: 20%
- Metapneumovirus: 10.6%
- Parainfluenza 1-4: 8.9%
- Adenovirus: 5.4%
- SARS-CoV-2: 3.4%
- Influenza A: 3.9%
- Influenza B: 1.6%
July 2024:
- Rhino/Enterovirus: 33.6%
- Rhinovirus: 21.2%
- RSV: 10.4%
- Metapneumovirus: 10.6%
- Parainfluenza 1-4: 9.6%
- Adenovirus: 3.8%
- SARS-CoV-2: 1.6%
- Influenza A: 3.9%
- Influenza B: 5.2%
1–5 Year Age Group
June 2024:
- Rhino/Enterovirus: 39.7%
- Rhinovirus: 24.9%
- Influenza B: 9.9%
- Metapneumovirus: 22.2%
- Parainfluenza 1-4: 8.1%
- Adenovirus: 8.6%
- RSV: 15.5%
- SARS-CoV-2: 1.2%
- Influenza A: 6.2%
July 2024:
- Rhino/Enterovirus: 45.8%
- Rhinovirus: 18.8%
- Influenza B: 19.1%
- Metapneumovirus: 7.5%
- Parainfluenza 1-4: 5.0%
- Adenovirus: 7.7%
- RSV: 11%
- SARS-CoV-2: 3.4%
- Influenza A: 4.9%
6–12 Year Age Group
June 2024:
- Rhino/Enterovirus: 41%
- Rhinovirus: 14.5%
- Influenza B: 22.6%
- RSV: 5.4%
- Metapneumovirus: 3.1%
- SARS-CoV-2: 6.0%
- Influenza A: 2.2%
- Adenovirus: 2.5%
- Parainfluenza 1-4: 2.6%
July 2024:
- Rhino/Enterovirus: 38.7%
- Rhinovirus: 6.2%
- Influenza B: 35%
- RSV: 3.1%
- Metapneumovirus: 3.6%
- SARS-CoV-2: 5.3%
- Influenza A: 0.5%
- Adenovirus: 1.1%
- Parainfluenza 1-4: 3.1%
Key Age-Specific Highlights:
- <1 year: RSV continues to circulate at high levels (20% in June)
- 1–5 years: Influenza B increased from 9.9% (June) to 19.1% (July)
- 6–12 years: Influenza B jumped from 22.6% (June) to 35% (July)
Continue Reading